Insights

345 Park Avenue South

Xchange Challenge

All floors are lab-ready and cabled for digital health.

Community

Apply for Membership

Residents

Leadership

Staff

Neighborhood

Be part of *Cure.*

Orange

Where scientists, entrepreneurs and visionaries converge.

Campus

Ecosystem

Event Spaces

Gallery

Networking hub

Space Availability

A place to *Succeed.*

Green

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

Critical Discussions Advancing Healthcare

Events

Event Inquiry

Past Events

Speakers

Tuesday Talks

Cure *Events.*

Magenta

Cure Clips

Tuesday Talks Series

Cure *Tuesday Talks*

Award Finalists to be announced soon!

Partnerships and Sponsorships

Women in Science

XSeed Award

Connect with *Opportunity.*

Blue

Network

Cure Insights Article A Bionic Pancreas that will Help Parents Sleep More Peacefully image for Cure Insights Mega Menu.  Image credit Cottonbro Studio.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

In-depth *Insights.*

About

Contact us

### About

Ryan Flinn has been a professional storyteller for more than 25 years, across both journalism and communications. He revels in translating complex science and technology news into meaningful articles.

### Experience

Flinn started his career as a journalist, working for a daily newspaper, a news wire service and eventually ending up at Bloomberg News. There, he covered breaking news, technology, biotech and wine. After more than a decade as a reporter, he changed careers and started advising companies on communications strategy. He worked at an agency before joining J&J Innovation, where he helped startups and dealmakers promote their science. After J&J, Flinn led all communications for two companies focused on the biotech space. In 2023, he started his own firm, In Like Flinn Communications, and divides his time between advising companies and freelance writing.  His articles have been published in *The New York Times*, *The San Francsico Chronicle*, *Businessweek*, *Evidence-Based Oncology*, *Managed Healthcare Executive* and Cure. He is the AI correspondent for BiotechTV and publishes a weekly newsletter, AI Rx, on how AI is transforming healthcare.

### Education

Flinn earned his B.A. in classics from the College of the Holy Cross in Worcester, MA.


Contributing Writer

Endpoints that reflect real-world value to patients can help startups improve enrollment and retention, and boost commercial success.

How Patient-Centered Trials Can Improve Biotech ROI

As Series B capital gets harder to secure, companies raise more in earlier rounds to reach value milestones.

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs Image HERO

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs

Newly released FDA complete response letters offer healthcare entrepreneurs insight into why drug applications fail and how to avoid the same mistakes.

What Startups Can Learn from FDA ‘No’ Letters

Open-source biological datasets Boltz-2 and Tahoe-100M are helping resource-strapped healthcare entrepreneurs and academic scientists accelerate drug discovery using AI but without the high data costs.

How Public Data Fuels the Next Wave of Drug Innovation

Faced with shrinking budgets, academic and industry life science researchers are making strategic partnerships their top priority.

Why Scientists and Startups are Doubling Down on Partnerships in 2025

CMS’s new Cell and Gene Therapy Access Model allows states to offer sickle cell gene therapies through federally negotiated contracts, reshaping CGT market for startups and rare disease therapeutics.



New Federal Program Expands Access to Gene Therapies for Sickle Cell and More

Despite a historic slump in biotech IPOs and venture funding, three women-led exits break through in a tough 2025.

Startups Face Bleak Funding While Women-Led Firms Score Rare M&A Wins

AI startups attracted most of the new digital health money in the first half of 2025, as investors focus on scaling proven technologies.

AI-Powered Companies Dominate 2025 Digital Health Funding

The Supreme Court’s decision upholding preventive care coverage under the Affordable Care Act signals a stable, growing market for healthcare startups and entrepreneurs.

Supreme Court Upholds Preventive Care Mandate — What It Means for Healthcare Innovation

The EU’s top health official said reforms will make Europe more attractive for drug developers as FDA changes create industry uncertainty.

Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty

In a move praised by advocates and physicians, the FDA eliminated post-treatment safety restrictions for CAR T therapies based on real-world data, potentially setting a precedent for regulatory flexibility for cell and gene therapies.

FDA Lifts Key Barriers to Immunotherapies Access, Signaling Regulatory Shift

The shortage of anti-obesity medications is sending patients to gray markets while healthcare innovators look for longer-term solutions beyond of GLP-1s.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Award Finalists to be announced soon!

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

Ryan Flinn

Articles by Ryan Flinn

How Patient-Centered Trials Can Improve Biotech ROI

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs

What Startups Can Learn from FDA ‘No’ Letters

How Public Data Fuels the Next Wave of Drug Innovation

Why Scientists and Startups are Doubling Down on Partnerships in 2025

New Federal Program Expands Access to Gene Therapies for Sickle Cell and More

Startups Face Bleak Funding While Women-Led Firms Score Rare M&A Wins

AI-Powered Companies Dominate 2025 Digital Health Funding

Supreme Court Upholds Preventive Care Mandate — What It Means for Healthcare Innovation

Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty

FDA Lifts Key Barriers to Immunotherapies Access, Signaling Regulatory Shift

How Entrepreneurs are Looking Beyond GLP-1s for Obesity Innovations

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Award Finalists to be announced soon!

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

Ryan Flinn

Articles by Ryan Flinn

How Patient-Centered Trials Can Improve Biotech ROI

‘Barbell Effect’ Reshapes Funding for Healthcare Entrepreneurs

What Startups Can Learn from FDA ‘No’ Letters

How Public Data Fuels the Next Wave of Drug Innovation

Why Scientists and Startups are Doubling Down on Partnerships in 2025

New Federal Program Expands Access to Gene Therapies for Sickle Cell and More

Startups Face Bleak Funding While Women-Led Firms Score Rare M&A Wins

AI-Powered Companies Dominate 2025 Digital Health Funding

Supreme Court Upholds Preventive Care Mandate — What It Means for Healthcare Innovation

Europe Makes Bold Bid to Attract Biotech Amid FDA Uncertainty

FDA Lifts Key Barriers to Immunotherapies Access, Signaling Regulatory Shift

How Entrepreneurs are Looking Beyond GLP-1s for Obesity Innovations

Cure Events.

Cure Tuesday Talks

In-depth Insights.